You're ready to work at the forefront of pharmaceutical sciences advancement. Take your education to the next level with a PhD at UBC Pharm Sci. It's where you'll work shoulder to shoulder with other world-class experts in the field of pharmaceutical sciences, contributing knowledge, developing solutions, and shaping the future of health care. Come to work every day at one of the world's most inspiring campuses, where you will find exceptional mentors and supervisors, and state-of-the-art facilities.
At UBC Pharm Sci, our research has shaped our outstanding international reputation. This is the place to collaborate with some of the world's foremost pharmaceutical experts, generating relevant, evidence-based and industry-focused research that makes a positive impact on broader society.
At UBC, we welcome diversity. Students come to us from a wide range of educational backgrounds and home countries. More than 50% of our graduate students come from other parts of the world, including the US and countries in Asia, Africa and Europe. We offer orientation events to help new students integrate into life here in Vancouver, at UBC and within the Faculty. And our Pharmaceutical Sciences Graduate Student Society (PharGS) will make you feel right at home.
Join Danielle Barkley, Educator and Career & Professional Development Advisor at UBC's Centre for Student Involvement and Careers, and Shane Moore, Marketing and Recruitment Manager. They'll be talking about aligning your graduate program with your career goals. They'll also be providing an overview of the wide range of career and professional development opportunities and support available at UBC. This session will be helpful to those still thinking about which graduate program is right for them, as well as applicants who know their program of study and want to better understand the support and guidance available at UBC.Register
To be considered for admission to the Pharm Sci PhD program, a COMPLETE application must be submitted by February 15th. Incomplete applications will NOT be considered. For International students: This includes a copy of the official IELTS or TOEFL transcript.
The Faculty of Graduate and Postdoctoral Studies establishes the minimum admission requirements common to all applicants, usually a minimum overall average in the B+ range (76% at UBC). The graduate program that you are applying to may have additional requirements. Please review the specific requirements for applicants with credentials from institutions in:
Each program may set higher academic minimum requirements. Please review the program website carefully to understand the program requirements. Meeting the minimum requirements does not guarantee admission as it is a competitive process.
Applicants from a university outside Canada in which English is not the primary language of instruction must provide results of an English language proficiency examination as part of their application. Tests must have been taken within the last 24 months at the time of submission of your application.
Minimum requirements for the two most common English language proficiency tests to apply to this program are listed below:
Overall score requirement: 100
Overall score requirement: 7.0
Some programs require additional test scores such as the Graduate Record Examination (GRE) or the Graduate Management Test (GMAT). The requirements for this program are:
The GRE is not required.
A minimum of three references are required for application to graduate programs at UBC. References should be requested from individuals who are prepared to provide a report on your academic ability and qualifications.
Many programs require a statement of interest, sometimes called a "statement of intent", "description of research interests" or something similar.
Students in research-based programs usually require a faculty member to function as their supervisor. Please follow the instructions provided by each program whether applicants should contact faculty members.
Permanent Residents of Canada must provide a clear photocopy of both sides of the Permanent Resident card.
All applicants must complete an online application form and pay the application fee to be considered for admission to UBC.
Pioneering research for the first drug-eluting coronary stent was accomplished by our Faculty The Neglected Global Diseases Initiative was developed in our Faculty. (http://ngdi.ubc.ca) Collaboration for Outcomes Research and Evaluation was developed in the Faculty of Pharmaceutical Sciences (https://core.ubc.ca/)
Genomics and individualized therapy. Epidemiology. Nanomedicine. Pharmacology. A MSc or PhD in pharmaceutical sciences is the entry point to countless fields of research and teaching. Graduates of UBC Pharm Sci have gone on to fine-tune treatments for diseases like tuberculosis, lecture internationally about female contraceptives, study the regulation of cardiac metabolism following diabetes, optimize medication dosages for organ transplantation, and improve mental health outcomes through a better understanding of antipsychotics. We are developing focused Graduate Training Programs that will allow MSc and PhD students to tailor their research and educational environments to suit their needs.
We moved into the new Pharmacy building in 2012 which houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities has been fitted with the necessary technology to facilitate new modes of learning. The Faculty houses a modern mass spectrometer facility of pharmacokinetic and drug metabolism studies and a Sequenom Mass-ARRAY system for genotyping and DNA methylation studies.
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,698.56||$2,984.09|
|Tuition per year|
(plus annual increase, usually 2%-5%)
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$944.51 (approx.)|
|Costs of living (yearly)||starting at $16,954.00 (check cost calculator)|
Applicants to UBC have access to a variety of funding options, including merit-based (i.e. based on your academic performance) and need-based (i.e. based on your financial situation) opportunities.
PhD students in the Faculty of Pharmaceutical Sciences are eligible to receive a stipend, provided they are in good standing and maintain their eligibility as a UBC graduate student. The stipend package normally includes a graduate teaching assistantship, a graduate research assistantship, and/or a scholarship.
The minimum stipend in the 2020-2021 academic year is:
Domestic PhD student: $25,825 per annum, which includes a President’s Academic Excellence Initiative PhD Award ($825)
International PhD student: $29,100 per annum, which includes an International Tuition Award ($3,200) and a President’s Academic Excellence Initiative PhD Award ($900 to each student whose tuition is not paid by an external sponsor)
Please be aware that due to the higher cost of living in Vancouver, students should plan to draw on their personal funds in addition to the stipend.
All applicants are encouraged to review the awards listing to identify potential opportunities to fund their graduate education. The database lists merit-based scholarships and awards and allows for filtering by various criteria, such as domestic vs. international or degree level.
Graduate programs may have Teaching Assistantships available for registered full-time graduate students. Full teaching assistantships involve 12 hours work per week in preparation, lecturing, or laboratory instruction although many graduate programs offer partial TA appointments at less than 12 hours per week. Teaching assistantship rates are set by collective bargaining between the University and the Teaching Assistants' Union.
Many professors are able to provide Research Assistantships (GRA) from their research grants to support full-time graduate students studying under their direction. The duties usually constitute part of the student's graduate degree requirements. A Graduate Research Assistantship is a form of financial support for a period of graduate study and is, therefore, not covered by a collective agreement. Unlike other forms of fellowship support for graduate students, the amount of a GRA is neither fixed nor subject to a university-wide formula. The stipend amounts vary widely, and are dependent on the field of study and the type of research grant from which the assistantship is being funded. Some research projects also require targeted research assistance and thus hire graduate students on an hourly basis.
Canadian and US applicants may qualify for governmental loans to finance their studies. Please review eligibility and types of loans.
All students may be able to access private sector or bank loans.
Many foreign governments provide support to their citizens in pursuing education abroad. International applicants should check the various governmental resources in their home country, such as the Department of Education, for available scholarships.
The possibility to pursue work to supplement income may depend on the demands the program has on students. It should be carefully weighed if work leads to prolonged program durations or whether work placements can be meaningfully embedded into a program.
Canadian residents with RRSP accounts may be able to use the Lifelong Learning Plan (LLP) which allows students to withdraw amounts from their registered retirement savings plan (RRSPs) to finance full-time training or education for themselves or their partner.
Please review Filing taxes in Canada on the student services website for more information.
Applicants have access to the cost calculator to develop a financial plan that takes into account various income sources and expenses.
48 students graduated between 2005 and 2013. Of these, career information was obtained for 42 alumni (based on research conducted between Feb-May 2016):
These statistics show data for the Doctor of Philosophy in Pharmaceutical Sciences (PhD). Data are separated for each degree program combination. You may view data for other degree options in the respective program profile.
|2017||Dr. Wehbe developed a method to form insoluble copper complexes inside lipid nanoparticles. This method allowed for the preclinical testing of copper-based therapeutics to treat blood, brain and ovarian cancers. His findings will aid in the design and development of future anti-cancer copper-based medicines.|
|2017||Dr. De La Vega's research revolved around rhenium, a silverish heavy metal and the last detected element. He formulated it into a diagnostic X-ray imaging agent, and, in radioactive form, into a therapeutic agent for liver cancer therapy. His work established the foundations for expanding rhenium's use in medical imaging and nuclear medicine.|
|2017||Dr. Zhang's study focused on the development of diabetes and its heart complication. He investigated an enzyme named 'haparanase', which facilitates the heart metabolic changes in diabetic patients, and could prevent the occurrence of diabetes if over produced. His work helps to revise the current use of heparanase as a therapeutic target.|
|2016||Dr. Chen studied the long-term development of respiratory diseases and how the progression of these diseases affects patients' overall health, quality of life and health care costs. She developed advanced models to examine how risk factors can be prevented at the onset of disease to ultimately help improve long-term health outcomes in these patients.|
|2016||Dr. Michaelsen studied lipid-based drug delivery systems to examine the mechanism behind increased drug absorption. Digestion was not found to play a role with regard to absorption however, drug load was. Her findings may provide guidance for future development of drug delivery systems for poorly water-soluble drugs.|
|2016||Dr. Schmitt studied drug concentrations in skin tissue fluid for use in therapeutic drug detection. She found that many drugs are detectable in skin tissue fluid and that their concentrations can be quite different from blood concentrations. In the future, this can lead to the development of blood- and pain- free drug monitoring devices.|
|2016||Dr. Sharma investigated how a group of anti-HIV drugs may cause therapy failure or toxicity. His results linked these drugs with certain proteins that control drug elimination processes in humans. Along with offering a rational basis for selection of anti-HIV therapy, his data provide novel therapeutic prospects for these drugs in other diseases.|
|2016||Dr. Knuhtsen worked on an interdisciplinary project within the fields of peptide chemistry and epigenetics. Based on a lead a library of peptides were synthesized which was used to identify an inhibitor of the enzyme family Protein Arginine Methyl Transferases. This inhibitor was subsequently characterized further.|
|2016||Dr. Bokharaei completed his doctoral degree in the field of nanomedicine and drug delivery at the the Faculty of Pharmaceutical Sciences. He designed and optimized a novel system that produces magnetic, protein-based, drug-filled microspheres. These biocompatible particles can be used for the imaging of lung diseases or for liver cancer therapy.|
|2015||Dr. Mohamed's doctoral studies focussed on development of inhibitors for the Rho-kinase enzyme. This enzyme plays an important role in the development of many diseases. Dr. Mohamed developed novel chemical inhibitors for the enzyme. His findings will aid in the design of new treatments for cardiovascular diseases, cancer and diabetes.|
Pharmaceutical Sciences covers research areas of nanomedicine, drug delivery; drug metabolism, pharmacokinetics and toxicology; pharmacogenomics and pharmacogenetics; diabetes, cardiovascular and molecular pharmacology; neuropharmacology; cancer pharmacology; pharmaceutical health outcomes and pharmacotherapeutics; and pharmaceutical education.